Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
US7517878B2 · kind B2 · utility
5Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2005 |
| Grant date | Apr 14, 2009 |
| Priority date | — |
| Expiry date | May 28, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.